Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Andrews

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Biorxiv : the Preprint Server for Biology|March 10, 2025
Apolipoprotein E abundance is elevated in the brains of individuals with Down syndrome-Alzheimer's diseaseClíona Farrell, Yazead Buhidma, Paige Mumford, et al.
Journal of the American Academy of Dermatology|December 4, 2023
Tape strips detect molecular alterations and cutaneous biomarkers in skin of patients with hidradenitis suppurativaKristina Navrazhina, Yael Renert-Yuval, Saakshi Khattri, et al.
Journal of the American Academy of Dermatology|October 26, 2024
A phase 2a trial of brepocitinib for cicatricial alopeciaEden David, Neda Shokrian, Ester Del Duca, et al.
BMC Public Health|July 14, 2019
Growing up in Bradford: protocol for the age 7-11 follow up of the Born in Bradford birth cohortPhilippa K Bird, Rosemary R C McEachan, Mark Mon-Williams, et al.
The Journal of Investigative Dermatology|September 24, 2023
Sclerotic-Type Cutaneous Chronic Graft-Versus-Host Disease Exhibits Activation of T Helper 1 and OX40 CytokinesMadeline Kim, Yael Renert-Yuval, Polina Stepensky, et al.
Nature Microbiology|January 10, 2018
Dynamics of metatranscription in the inflammatory bowel disease gut microbiomeMelanie Schirmer, Eric A Franzosa, Jason Lloyd-Price, et al.
Nature Medicine|May 8, 2023
A deep learning algorithm to predict risk of pancreatic cancer from disease trajectoriesDavide Placido, Bo Yuan, Jessica X Hjaltelin, et al.
JCO Precision Oncology|June 21, 2023
Highly Sensitive Circulating Tumor DNA Assay Aids Clinical Management of Radiographically Occult Isolated Peritoneal Metastases in Patients With GI CancerHarshabad Singh, Samuel J Klempner, Nelya Melnitchouk, et al.
Nature Communications|August 9, 2024
Clinical outcomes and ctDNA correlates for CAPOX BETR: a phase II trial of capecitabine, oxaliplatin, bevacizumab, trastuzumab in previously untreated advanced HER2+ gastroesophageal adenocarcinomaHarshabad Singh, Kristen E Lowder, Kevin Kapner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 11, 2023
A Phase I Expansion Cohort Study Evaluating the Safety and Efficacy of the CHK1 Inhibitor LY2880070 with Low-dose Gemcitabine in Patients with Metastatic Pancreatic AdenocarcinomaBrandon M Huffman, Hanrong Feng, Kalindi Parmar, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Biorxiv : the Preprint Server for Biology|March 10, 2025
Apolipoprotein E abundance is elevated in the brains of individuals with Down syndrome-Alzheimer's diseaseClíona Farrell, Yazead Buhidma, Paige Mumford, et al.
Journal of the American Academy of Dermatology|December 4, 2023
Tape strips detect molecular alterations and cutaneous biomarkers in skin of patients with hidradenitis suppurativaKristina Navrazhina, Yael Renert-Yuval, Saakshi Khattri, et al.
Journal of the American Academy of Dermatology|October 26, 2024
A phase 2a trial of brepocitinib for cicatricial alopeciaEden David, Neda Shokrian, Ester Del Duca, et al.
BMC Public Health|July 14, 2019
Growing up in Bradford: protocol for the age 7-11 follow up of the Born in Bradford birth cohortPhilippa K Bird, Rosemary R C McEachan, Mark Mon-Williams, et al.
The Journal of Investigative Dermatology|September 24, 2023
Sclerotic-Type Cutaneous Chronic Graft-Versus-Host Disease Exhibits Activation of T Helper 1 and OX40 CytokinesMadeline Kim, Yael Renert-Yuval, Polina Stepensky, et al.
Nature Microbiology|January 10, 2018
Dynamics of metatranscription in the inflammatory bowel disease gut microbiomeMelanie Schirmer, Eric A Franzosa, Jason Lloyd-Price, et al.
Nature Medicine|May 8, 2023
A deep learning algorithm to predict risk of pancreatic cancer from disease trajectoriesDavide Placido, Bo Yuan, Jessica X Hjaltelin, et al.
JCO Precision Oncology|June 21, 2023
Highly Sensitive Circulating Tumor DNA Assay Aids Clinical Management of Radiographically Occult Isolated Peritoneal Metastases in Patients With GI CancerHarshabad Singh, Samuel J Klempner, Nelya Melnitchouk, et al.
Nature Communications|August 9, 2024
Clinical outcomes and ctDNA correlates for CAPOX BETR: a phase II trial of capecitabine, oxaliplatin, bevacizumab, trastuzumab in previously untreated advanced HER2+ gastroesophageal adenocarcinomaHarshabad Singh, Kristen E Lowder, Kevin Kapner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 11, 2023
A Phase I Expansion Cohort Study Evaluating the Safety and Efficacy of the CHK1 Inhibitor LY2880070 with Low-dose Gemcitabine in Patients with Metastatic Pancreatic AdenocarcinomaBrandon M Huffman, Hanrong Feng, Kalindi Parmar, et al.
Pageof 7